Accelercomm
Accelercomm is a leader in high-performance wireless communications solutions. The University of Southampton spin-out has developed patented communications algorithms for 5G, doubling network capacity whilst halving power consumption and slashing latency. Accelercomm’s patent-protected solutions offer a complete physical layer IP solution enabling optimal performance for 5G radio access networks.
adsilico
adsilico is developing an end-to-end in-silico trials solution based on virtual ‘synthetic patient populations that will provide better and safer medical devices earlier to patients, reduce costs and accelerate R&D timescales for medical device developers, contribute to animal welfare by reducing animal experimentation, reducing refining and partially replacing costly and potentially harmful human trials.
Barocal
Barocal is developing a zero global warming potential (GWP) alternative to fluid refrigerants, harnessing the barocaloric effect (BCE) in solid refrigerants, where materials undergo large thermal changes on application and removal of pressure to develop cooling and heating systems.
Brainomix
Brainomix is aiming to improve stroke treatment dramatically by developing systems that gives all hospitals and clinics access to reliable diagnoses for their patients. The Brainomix e-ASPECTS platform is first system in the world to provide automated, standardised analysis of CT brain scans for stroke damage, assessing patients’ suitability for life saving treatment.
Cambridge GaN Devices
Cambridge GaN Devices (CGD) is a spin out from the High Voltage Microelectronics and Sensors lab at the University of Cambridge Engineering Department. The lab has a successful track record of commercialising innovation and one of the founders, Florin Udrea, was behind the success of Cambridge CMOS Sensors; a Cambridge spin out in an adjacent technology that was backed by Parkwalk and Cambridge Enterprise to a successful trade sale exit in 2016.
Ceryx Medical
Ceryx Medical are a pioneering company in the emerging field of bioelectronic medicine. Spun out from the Universities of Bath and Bristol in 2016 following successful joint scientific research programmes, Ceryx Medical is developing a unique bioelectronic technology which can mimic nerve centres within the body called Central Pattern Generators (CPGs). These CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate and even walking. The first application for this technology is in a new cardiac pacemaker that has the potential to be the world’s first curative therapy for heart failure.
Crypto Quantique
Crypto Quantique is an Internet of Things (IoT) security company with a mission to revolutionise the IoT with quantum driven cybersecurity. The company provides a dual hardware and software end-to-end solution to current and future cyber security threats to IoT security.
Echopoint
Echopoint Medical Limited is a University College London (UCL) spin-out, which has developed core photonic sensor technology to greatly enhance the diagnosis and treatment of coronary heart disease.
Echopoint was founded upon the research of Dr Adrien Desjardins, Dr Malcolm Finlay, Dr Ioannis Papakonstantinou and Dr Richard Colchester. The core research has attracted grants totalling £5.8M during its development over a decade as well as generating over 50 peer reviewed publications.
MoA Technology
MoA Technology is a plant genetics company using its proprietary technology to generate potential candidates for use as herbicides. The herbicide market mirrors the antibiotic market, in that there have been few new molecules developed in recent years and resistance is developing to those products on the market.
Oxa
Oxa is an autonomous vehicle software company whose technology operates in any location with zero dependence on external systems i.e. no GPS and no third-party maps. Its autonomous control system, Selenium, is a suite of software that combines data from vehicle sensors to drive autonomous vehicles. The Company’s cloud-based fleet management system, Caesium, schedules and co-ordinates autonomous vehicles, optimising routes and exchanging data without human intervention.
Paragraf
Paragraf is the first company in the world to mass produce graphene-based electronic devices using standard semiconductor processes in order to materially impact critical global challenges by driving a 2D-material revolution in the semiconductor industry.
PervasID
PervasID provides unique, passive radio frequency identification (RFID) solutions with unrivalled detection capability and enables sophisticated IoT infrastructures. The technology outperforms current passive technologies and is cheaper but as accurate as active RFID systems. PervasID’s unique passive RFID tag reader technology for retail, healthcare and security sectors tracks items, increases revenue and reduces shrinkage.
Quantum Motion
Quantum Motion Technology is developing a revolutionary technology platform using a scalable array of qubits to create quantum computing architectures that are compatible with standard silicon processing. By creating a scalable quantum computing technology the Company will be able to tackle currently intractable problems in fields as diverse as chemistry, medicine and artificial intelligence.
Symetrica
Symetrica specializes in the detection and identification of radioisotopes for Security Applications. The company works with prime contractors and government agencies to design, develop, test and deploy detection equipment for use by law enforcement personnel, customs officers, the emergency services, military personnel and first responders.
Xampla
Xampla is developing a novel class of plant-protein materials which provide natural alternatives to plastics. These materials can be manufactured in a wide variety of forms, including films, threads, gels and microbeads, and all have a high degree of biodegradability.
